SAMRAT PHARMACHEM LTD.

NSE : NABSE : 530125ISIN CODE : INE103E01016Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 1188.76 Face Value (Rs.) : 10 House : Private
BSECurrent Price (Rs.) 384.75Change (Rs.)-4.25 (-1.09 %)
PREV CLOSE (Rs.) 389.00
OPEN PRICE (Rs.) 384.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1523
TODAY'S LOW / HIGH (Rs.)383.00 404.70
52 WK LOW / HIGH (Rs.) 320646
NSE
This Company is not listed in NSE

Board Meeting

Source Date Board Meeting Date Details
31-Dec-202414-Feb-2025 Quarterly Results
27-Sep-202414-Nov-2024 Quarterly Results
01-Jul-202413-Aug-2024 Quarterly Results
28-Mar-202430-May-2024 Final Dividend & Audited Results
29-Dec-202314-Feb-2024 Quarterly Results
26-Sep-202308-Nov-2023 Quarterly Results
30-Jun-202314-Aug-2023 Quarterly Results
28-Mar-202330-May-2023 Dividend & Audited Results
01-Mar-202316-Mar-2023 Inter alia, to consider and approve re-appointment of 3 Executive Directors of the company namely, Mr. Lalit Mehta, Chairman & Managing Director (DIN: 00216681), Mr. Rajesh Mehta, Executive Director (DIN: 00216731) & Mr. Megh Mehta, Executive Director (DIN: 07287394) for a further period of 3 years effective from April 1, 2023 to March 31, 2026, based on the recommendations of the Nomination & Remuneration Committee and to approve the re-appointment through the postal ballot.
30-Sep-202214-Nov-2022 Quarterly Results